AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30626198 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and other drug (AOD) use
Number of subjects: 185
Study 30626198 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual behavior
Number of subjects: 185
Study 30626198 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental and physical health
Number of subjects: 185
Study 30626198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural practices
Number of subjects: 185
Study 30626198 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrimination experiences
Number of subjects: 185
Study 31786466 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib (VEGFR2 inhibitor)
Number of subjects: 42
Study 30535668 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid arm (methylprednisone)
Number of subjects: 7406
Study 30535668 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 7406
Study 29089468 — intervention group
Group type: EXPERIMENTAL
Intervention: HTK solution
Number of subjects: 50
Study 29089468 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 25245572 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei subsp. paracasei L. casei W8 (1010 cfu)
Number of subjects: 64
Study 25245572 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo capsules)
Number of subjects: 64
Study 23900469 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucometer for SMBG
Number of subjects: 105
Study 23900469 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 105
Study 21853766 — intervention group
Group type: EXPERIMENTAL
Intervention: Colored filters
Number of subjects: 27
Study 21853766 — intervention group
Group type: COMPARATOR
Intervention: Control group (no colored filters)
Number of subjects: 27
Study 21095276 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHERE patients
Number of subjects: 82074
Study 21095276 — intervention group
Group type: COMPARATOR
Intervention: ADHERE hospitals
Number of subjects: 82074
Study 17094103 — intervention group
Group type: EXPERIMENTAL
Intervention: Entacapone 100 mg
Number of subjects: 341
Study 17094103 — intervention group
Group type: EXPERIMENTAL
Intervention: Entacapone 200 mg
Number of subjects: 341
Study 17094103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study 15735185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 600
Study 15735185 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 600
Study 12060504 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% penciclovir cream
Number of subjects: 248
Study 12060504 — intervention group
Group type: COMPARATOR
Intervention: 3% aciclovir cream
Number of subjects: 248
Study 9857648 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (mitomycin, cisplatin, vinblastine)
Number of subjects: 30
Study 7832135 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 15
Study 7832135 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 15
Study 7832135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2225705 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 to 100 mg once a day)
Number of subjects: 30
Study 2225705 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (2.5 to 40 mg once a day)
Number of subjects: 30
Study 552658 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg RG 033
Number of subjects: 30
Study 552658 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg RG 033
Number of subjects: 30
Study 552658 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study 30666357 — intervention group
Group type: EXPERIMENTAL
Intervention: GI-irAEs (Any grade)
Number of subjects: 346
Study 30666357 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade diarrhea
Number of subjects: 346
Study 30666357 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with GI-irAEs
Number of subjects: 346
Study 30666357 — intervention group
Group type: COMPARATOR
Intervention: ECOG 2–3
Number of subjects: 346
Study 30666357 — intervention group
Group type: COMPARATOR
Intervention: LDH ≥ 618 IU/L
Number of subjects: 346
Study 30666357 — intervention group
Group type: COMPARATOR
Intervention: Stage M1c
Number of subjects: 346
Study 30666357 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive treatment
Number of subjects: 346
Study 28394172 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter total wake time (TWT) before treatment session
Number of subjects: 188
Study 28394172 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter total wake time (TWT) after treatment session
Number of subjects: 188
Study 28394172 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter total sleep time (TST) before treatment session
Number of subjects: 188
Study 28394172 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter total sleep time (TST) after treatment session
Number of subjects: 188
Study 25911605 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslipidemia
Number of subjects: 3178
Study 25911605 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 3178
Study 25911605 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemia
Number of subjects: 3178
Study 25911605 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 3178
Study 25911605 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 3178
Study 25911605 — intervention group
Group type: EXPERIMENTAL
Intervention: Order of risk factor accrual
Number of subjects: 3178
Study 23430381 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 L PEG‐electrolyte solution plus 15 mg of mosapride
Number of subjects: 252
Study 23430381 — intervention group
Group type: COMPARATOR
Intervention: 2 L PEG‐electrolyte solution plus 15 mg of mosapride
Number of subjects: 252
Study 21276584 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet Eye (QE) training
Number of subjects: 16
Study 21276584 — intervention group
Group type: COMPARATOR
Intervention: Control group (technical instruction only)
Number of subjects: 16
Study 20141094 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made foot orthoses
Number of subjects: 0
Study 20141094 — intervention group
Group type: COMPARATOR
Intervention: Prefabricated foot orthoses
Number of subjects: 0
Study 16934044 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-prenylnaringenin (8-PN) 750 mg
Number of subjects: 24
Study 15195722 — intervention group
Group type: COMPARATOR
Intervention: Conventional cement (Fuji I, GC)
Number of subjects: 209
Study 15195722 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin modified GI luting cement (Rely X, 3M/ESPE)
Number of subjects: 209
Study 11168705 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical supervision
Number of subjects: 211
Study 11168705 — intervention group
Group type: COMPARATOR
Intervention: Unsupervized nurses
Number of subjects: 211
Study 11168705 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervized nurses (junior grades)
Number of subjects: 211
Study 9268276 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive structured individual assessment with specific safety recommendations
Number of subjects: 482
Study 8328683 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifenprodil
Number of subjects: 20
Study 8328683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3573654 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol 1%
Number of subjects: 19
Study 3573654 — intervention group
Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 19
Study 29309023 — intervention group
Group type: EXPERIMENTAL
Intervention: FM + CCS
Number of subjects: 99
Study 29309023 — intervention group
Group type: EXPERIMENTAL
Intervention: FM + AT + CCS
Number of subjects: 99
Study 29309023 — intervention group
Group type: COMPARATOR
Intervention: AT + CCS
Number of subjects: 99
Study 29309023 — intervention group
Group type: COMPARATOR
Intervention: CCS
Number of subjects: 99
Study 27045280 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser (100mW, 830nm)
Number of subjects: 15
Study 27045280 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (30U first session, 15U after 15 days)
Number of subjects: 15
Study 27045280 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser and Botulinum toxin type A
Number of subjects: 15
Study 24899217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive workshop on evidence-based management of seasonal allergic rhinitis
Number of subjects: 246
Study 24899217 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 246
Study 21839654 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA) in addition to medical therapy (immediate treatment group - ITG)
Number of subjects: 15
Study 21839654 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA) after 6 months of medical therapy alone (delayed treatment group - DTG)
Number of subjects: 15
Study 21839654 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) results in immediate treatment group (ITG)
Number of subjects: 15
Study 21839654 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI) results in delayed treatment group (DTG)
Number of subjects: 15
Study 19717488 — intervention group
Group type: COMPARATOR
Intervention: Skeletal muscle OB-R170 protein expression in obese men
Number of subjects: 20
Study 19717488 — intervention group
Group type: COMPARATOR
Intervention: SOCS3 protein expression in obese subjects
Number of subjects: 20
Study 19717488 — intervention group
Group type: COMPARATOR
Intervention: Basal STAT3, AMPKalpha and ACCbeta phosphorylation levels in obese subjects
Number of subjects: 20
Study 18656045 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training method
Number of subjects: 30
Study 18656045 — intervention group
Group type: COMPARATOR
Intervention: Standard training method
Number of subjects: 30
Study 16264053 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP therapy (Continuous Positive Airway Pressure)
Number of subjects: 31
Study 12135820 — intervention group
Group type: EXPERIMENTAL
Intervention: Group support program
Number of subjects: 187
Study 12135820 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visit program
Number of subjects: 187
Study 12135820 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 187
Study 12135820 — intervention group
Group type: COMPARATOR
Intervention: Group support program vs Control group
Number of subjects: 187
Study 12135820 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visit program vs Group support program
Number of subjects: 187
Study 12135820 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger female caregivers
Number of subjects: 187
Study 10198952 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain-clothes (PC) group
Number of subjects: 57
Study 10198952 — intervention group
Group type: COMPARATOR
Intervention: Hospital gown (HG) group
Number of subjects: 57
Study 7826293 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (insulin administration at least three times a day, adjusted based on self-blood glucose monitoring, aiming for normoglycemia)
Number of subjects: 1441
Study 7826293 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (one or two daily insulin injections)
Number of subjects: 1441
Study 7826293 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 1441
Study 2136063 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal clonidine
Number of subjects: 9
Study 2136063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 305522 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg Biarison
Number of subjects: 12
Study 305522 — intervention group
Group type: COMPARATOR
Intervention: 100 mg indometacin
Number of subjects: 12
Study 305522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 305522 — intervention group
Group type: COMPARATOR
Intervention: 900 mg Biarison (under double blind conditions)
Number of subjects: 12
Study 31874153 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenursing
Number of subjects: 90
Study 31874153 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face training
Number of subjects: 90
Study 31874153 — intervention group
Group type: COMPARATOR
Intervention: Control (regular care)
Number of subjects: 90
Study 30055303 — intervention group
Group type: EXPERIMENTAL
Intervention: DNS-7801 solutions
Number of subjects: 0
Study 30055303 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of citrate buffer at pH 3.0 and hydroxypropylbetadex
Number of subjects: 0
Study 27385940 — intervention group
Group type: COMPARATOR
Intervention: CSE alone
Number of subjects: 92
Study 27385940 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE with lumbar plexus block (LPB)
Number of subjects: 92
Study 24676950 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical scenario-based simulation education for communication
Number of subjects: 122
Study 24676950 — intervention group
Group type: COMPARATOR
Intervention: Traditional class-based education for communication
Number of subjects: 122
Study 22425235 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (8 weeks of gym-based aerobic and strengthening exercises, 3 times a week)
Number of subjects: 14
Study 22425235 — intervention group
Group type: COMPARATOR
Intervention: Control group (mobilization alone)
Number of subjects: 14
Study 20389223 — intervention group
Group type: EXPERIMENTAL
Intervention: Interview based on the theory of culture care by a nurse before visiting a gastroenterologist (Intervention group)
Number of subjects: 39
Study 20389223 — intervention group
Group type: COMPARATOR
Intervention: Standard medical examination by a gastroenterologist (Control group)
Number of subjects: 39
Study 18402630 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine treatment for 8 weeks
Number of subjects: 8
Study 15836938 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic analysis of force platform data in children with cerebral palsy
Number of subjects: 0
Study 15836938 — intervention group
Group type: COMPARATOR
Intervention: Harmonic analysis of force platform data in normal children (control group)
Number of subjects: 0
Study 12115152 — intervention group
Group type: EXPERIMENTAL
Intervention: Numerical Rating Scale (NRS)
Number of subjects: 536
Study 12115152 — intervention group
Group type: COMPARATOR
Intervention: Visual Analog Scale (VAS) and Likert scale
Number of subjects: 536
Study 10862536 — intervention group
Group type: COMPARATOR
Intervention: FIO2: 0.21 (room air breathing)
Number of subjects: 25
Study 10862536 — intervention group
Group type: EXPERIMENTAL
Intervention: FIO2: 0.26 (increased FIO2)
Number of subjects: 25
Study 8884760 — intervention group
Group type: EXPERIMENTAL
Intervention: alprazolam
Number of subjects: 12
Study 8884760 — intervention group
Group type: EXPERIMENTAL
Intervention: bromazepam
Number of subjects: 12
Study 8884760 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 1993795 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 18
Study 1993795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6652271 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-mask during sleep
Number of subjects: 20
Study 30518246 — intervention group
Group type: EXPERIMENTAL
Intervention: BE-ACTIV intervention
Number of subjects: 41
Study 27809558 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga intervention (8 weeks)
Number of subjects: 118
Study 27809558 — intervention group
Group type: COMPARATOR
Intervention: Stretching control group (8 weeks)
Number of subjects: 118
Study 25564724 — intervention group
Group type: EXPERIMENTAL
Intervention: Twins
Number of subjects: 1970
Study 25564724 — intervention group
Group type: EXPERIMENTAL
Intervention: African-Americans
Number of subjects: 1970
Study 25564724 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing gestational age at membrane rupture
Number of subjects: 1970
Study 24796044 — intervention group
Group type: EXPERIMENTAL
Intervention: Jingjin acupuncture treatment (including acupuncture on palm side of affected hand, dorsal metacarpophalangeal joints, and proximal interphalangeal joints, once every other day, with electroacupuncture when qi was acquired)
Number of subjects: 50
Study 24796044 — intervention group
Group type: COMPARATOR
Intervention: Regular acupuncture (Shuigou (GV 26), Baihui (GV 20), Neiguan (PC 6), etc.)
Number of subjects: 50
Study 24796044 — intervention group
Group type: EXPERIMENTAL
Intervention: Jingjin acupuncture treatment
Number of subjects: 50
Study 24796044 — intervention group
Group type: COMPARATOR
Intervention: Regular acupuncture
Number of subjects: 50
Study 22892393 — intervention group
Group type: EXPERIMENTAL
Intervention: trastuzumab
Number of subjects: 210
Study 22892393 — intervention group
Group type: EXPERIMENTAL
Intervention: lapatinib
Number of subjects: 210
Study 20384388 — intervention group
Group type: EXPERIMENTAL
Intervention: DRSP 3 mg/EE 30 microg
Number of subjects: 0
Study 20384388 — intervention group
Group type: COMPARATOR
Intervention: LNG 150 microg/EE 30 microg
Number of subjects: 0
Study 18821656 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobics
Number of subjects: 30
Study 18821656 — intervention group
Group type: COMPARATOR
Intervention: Qigong
Number of subjects: 30
Study 15956121 — intervention group
Group type: COMPARATOR
Intervention: Ischemic exercise training (ET) for 4 weeks in patients with PAOD
Number of subjects: 3
Study 15956121 — intervention group
Group type: COMPARATOR
Intervention: Nonischemic exercise training (ET) for 4 weeks in successfully revascularized patients with PAOD
Number of subjects: 3
Study 15956121 — intervention group
Group type: COMPARATOR
Intervention: Subischemic exercise training (ET) for 4 weeks in patients with stable coronary artery disease
Number of subjects: 3
Study 12427152 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral l‐folinic acid at 20 mg/day
Number of subjects: 48
Study 12427152 — intervention group
Group type: COMPARATOR
Intervention: Oral folic acid at 15 mg/day
Number of subjects: 48
Study 10048736 — intervention group
Group type: EXPERIMENTAL
Intervention: H- II and FS (Flexible Sigmoidoscopy)
Number of subjects: 10978
Study 10048736 — intervention group
Group type: COMPARATOR
Intervention: H- II alone
Number of subjects: 10978
Study 7793558 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine 1.5 mg.kg‐1
Number of subjects: 80
Study 7793558 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride 0.9% (Control)
Number of subjects: 80
Study 1941800 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervex-Brush
Number of subjects: 1136
Study 1941800 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytobrush plus spatula
Number of subjects: 1136
Study 1941800 — intervention group
Group type: COMPARATOR
Intervention: Control method (Ayre spatula with cotton swab or alone)
Number of subjects: 1136
Study 6193472 — intervention group
Group type: EXPERIMENTAL
Intervention: cis‐DDP and bleomycin (arm A)
Number of subjects: 52
Study 6193472 — intervention group
Group type: COMPARATOR
Intervention: methotrexate and vindesine (arm B)
Number of subjects: 52
Study 6193472 — intervention group
Group type: EXPERIMENTAL
Intervention: crossover from B to A
Number of subjects: 52
Study 6193472 — intervention group
Group type: EXPERIMENTAL
Intervention: patients resistant to B treated with A
Number of subjects: 52
Study 31802570 — intervention group
Group type: EXPERIMENTAL
Intervention: ENTREN-F programme (family intervention)
Number of subjects: 70
Study 31802570 — intervention group
Group type: COMPARATOR
Intervention: ENTREN programme (psychological intervention for children)
Number of subjects: 70
Study 30033514 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina supplement (2 g/day) plus conventional regimen (220 mg/day zinc sulfate, 500 mg/day L-carnitine, and 50 mg/day clomiphene)
Number of subjects: 40
Study 30033514 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus conventional therapy
Number of subjects: 40
Study 29924797 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient Therapeutic Program (OTP) for SAM
Number of subjects: 494
Study 26956541 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (10 treatments over 8 weeks)
Number of subjects: 160
Study 26956541 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (7 sessions over 8 weeks)
Number of subjects: 160
Study 25164487 — intervention group
Group type: EXPERIMENTAL
Intervention: Muffins made with sunflower oil (SFO)
Number of subjects: 20
Study 18457100 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal‐epidural and general anesthesia (CSEGA)
Number of subjects: 16
Study 18457100 — intervention group
Group type: COMPARATOR
Intervention: Combined spinal and general anesthesia (CSGA)
Number of subjects: 16
Study 15355149 — intervention group
Group type: EXPERIMENTAL
Intervention: New syntactic construction
Number of subjects: 0
Study 15355149 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience with the novel construction
Number of subjects: 0
Study 15355149 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel construction
Number of subjects: 0
Study 11003072 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available metal detector
Number of subjects: 10
Study 11003072 — intervention group
Group type: COMPARATOR
Intervention: Standard confirmatory radiographic imaging
Number of subjects: 10
Study 9481274 — intervention group
Group type: EXPERIMENTAL
Intervention: Changing vascular equipment every 72 hours
Number of subjects: 211
Study 9481274 — intervention group
Group type: COMPARATOR
Intervention: Changing vascular equipment every 48 hours (Control Group)
Number of subjects: 211
Study 8493299 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 9
Study 8493299 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin (Gn)
Number of subjects: 9
Study 8493299 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 9
Study 3327710 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylcellulose (25 eyes)
Number of subjects: 66
Study 3327710 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (22 eyes)
Number of subjects: 66
Study 3327710 — intervention group
Group type: COMPARATOR
Intervention: Air (19 eyes)
Number of subjects: 66